These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7903061)

  • 1. Therapeutic applications of somatostatin and its analogue octreotide.
    Harris AG; Kokoris SP
    Eur J Med; 1993 Feb; 2(2):97-105. PubMed ID: 7903061
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential gastrointestinal uses of somatostain and its synthetic analogue octreotide.
    Grosman I; Simon D
    Am J Gastroenterol; 1990 Sep; 85(9):1061-72. PubMed ID: 1975156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders.
    Masclee AA; Jansen JB; Lamers CB
    Neth J Med; 1991 Dec; 39(5-6):356-65. PubMed ID: 1687076
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of somatostatin in the management of upper gastrointestinal bleeding].
    Herszényi L
    Orv Hetil; 2002 May; 143(19 Suppl):1092-9. PubMed ID: 12063868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology.
    Camisa C
    Arch Dermatol; 1989 Mar; 125(3):407-12. PubMed ID: 2564269
    [No Abstract]   [Full Text] [Related]  

  • 6. [Somatostatin and SMS 201-995 (octreotide): clinical and therapeutic aspects].
    da Silva PM; Augusto F
    Acta Med Port; 1993 Jan; 6(1):25-31. PubMed ID: 8097350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide, a somatostatin analogue, attenuates movement evoked discharges of fine afferent units from inflamed knee joints of rats.
    Pawlak M; Schmidt RF
    Neurosci Lett; 2004 May; 361(1-3):180-3. PubMed ID: 15135923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of somatostatin and its long-acting analogue, octreotide, in the treatment of pancreatic diseases.
    Delmont J; Hastier P; Dumas R
    Aliment Pharmacol Ther; 1995 Oct; 9(5):581-3. PubMed ID: 8580282
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
    Ma P; Wang Y; van der Hoek J; Nedelman J; Schran H; Tran LL; Lamberts SW
    Clin Pharmacol Ther; 2005 Jul; 78(1):69-80. PubMed ID: 16003295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of somatostatin and octreotide on experimental and human acute pancreatitis.
    Greenberg R; Haddad R; Kashtan H; Kaplan O
    J Lab Clin Med; 2000 Feb; 135(2):112-21. PubMed ID: 10695655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a somatostatin analogue in occult gastrointestinal bleeding: a case report.
    Tamagno G; Mioni R; De Carlo E; Maffei P; Rubello D; Sicolo N
    Dig Liver Dis; 2004 Dec; 36(12):843-6. PubMed ID: 15646433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy.
    Vanheule E; Geerts AM; Reynaert H; Van Vlierberghe H; Geerts A; De Vos M; Colle I
    Liver Int; 2008 Jan; 28(1):107-16. PubMed ID: 18173562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin and somatostatin analogues in human breast carcinoma.
    Prévost G; Israel L
    Recent Results Cancer Res; 1993; 129():63-70. PubMed ID: 8102489
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin and octreotide on the treatment of acute pancreatitis - basic and clinical studies for three decades.
    Li J; Wang R; Tang C
    Curr Pharm Des; 2011; 17(16):1594-601. PubMed ID: 21548873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Poon RT; Fan ST
    JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma.
    Morris DL
    Cancer; 1996 May; 77(9):1956-7. PubMed ID: 8646698
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatostatin analogues in the treatment of pancreatic neoplasia.
    Müller MK
    Recent Results Cancer Res; 1993; 129():57-62. PubMed ID: 8102488
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes].
    Sperlongano P; De Falco M; Pisaniello D; Parmeggiani D; Parmeggiani U
    Minerva Endocrinol; 2001 Dec; 26(4):293-5. PubMed ID: 11782719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
    Closset J; Journe S; Mboti F; El Nakadi I; Gelin M
    Hepatogastroenterology; 2008; 55(86-87):1818-23. PubMed ID: 19102400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin analogue (SMS 201-995) but not somatostatin reduces indocyanine green clearance in the portal hypertensive rat.
    Kimchi N; Krepel Z; Ronen E; Bar-Meir E; Bruck R; Bar-Meir S
    Isr J Med Sci; 1993 Jan; 29(1):37-9. PubMed ID: 8095929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.